Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
- PMID: 9578413
Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
Abstract
Melanoma progression in general is characterized by an increase in both metastatic frequency and the vascular density of the tumour tissue. Although a direct correlation between these two parameters in individual cases seems to be lacking, it is clear that metastasis is invariably preceded by angiogenesis. One of the angiogenic factors that is produced by human melanoma cells is vascular endothelial growth factor (VEGF). To investigate the role of this factor in the angiogenic process in primary cutaneous melanoma we determined the mean vascular density and the presence of VEGF protein in biopsies of human lesions. The results were compared with those found in normal skin or uninvolved skin from melanoma patients. In addition, we studied morphological and antigenic features of the proliferating neovasculature. We show that (1) the mean vascular density gradually rises along with melanoma progression, (2) transition of horizontal to vertical growth phase melanoma is accompanied by induction of VEGF protein expression and accumulation of this factor in the stroma, (3) vertical growth phase melanoma is often organized in nodules separated by septa containing blood vessels, but without lymphatics, and (4) blood vessel lumina in vertical growth phase melanoma are separated from tumour nodules by two basal lamina containing collagen type IV and the endothelium shows activated morphology and focal expression of the adhesion molecule E-selectin. Our findings indicate that VEGF is a prominent angiogenic factor in melanoma angiogenesis. Although its expression is induced during progression, the effect of VEGF on the incidence of metastasis is probably indirect.
Similar articles
-
Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.Cancer Res. 2000 Sep 1;60(17):4932-8. Cancer Res. 2000. PMID: 10987309
-
Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.Cancer Res. 2001 Oct 1;61(19):7282-90. Cancer Res. 2001. PMID: 11585767
-
Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.Br J Cancer. 1999 Aug;80(11):1697-707. doi: 10.1038/sj.bjc.6690586. Br J Cancer. 1999. PMID: 10468285 Free PMC article.
-
[Angiogenesis and tumor progression in melanoma].Recenti Prog Med. 2000 Nov;91(11):581-7. Recenti Prog Med. 2000. PMID: 11125952 Review. Italian.
-
Angiogenesis, lymphangiogenesis, and melanoma metastasis.Oncogene. 2003 May 19;22(20):3172-9. doi: 10.1038/sj.onc.1206457. Oncogene. 2003. PMID: 12789293 Review.
Cited by
-
Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.Am J Pathol. 2002 Mar;160(3):1009-19. doi: 10.1016/S0002-9440(10)64922-X. Am J Pathol. 2002. PMID: 11891198 Free PMC article.
-
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.Clin Cancer Res. 2024 Jun 14;30(12):2623-2635. doi: 10.1158/1078-0432.CCR-23-3196. Clin Cancer Res. 2024. PMID: 38530846 Free PMC article. Clinical Trial.
-
Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanoma.Clin Cancer Res. 2012 Jun 15;18(12):3328-39. doi: 10.1158/1078-0432.CCR-11-3000. Epub 2012 Apr 10. Clin Cancer Res. 2012. PMID: 22496203 Free PMC article.
-
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.Br J Cancer. 2012 Sep 4;107(6):977-87. doi: 10.1038/bjc.2012.355. Epub 2012 Aug 14. Br J Cancer. 2012. PMID: 22892389 Free PMC article.
-
Angiogenesis and melanoma.Cancers (Basel). 2010 Feb 25;2(1):114-32. doi: 10.3390/cancers2010114. Cancers (Basel). 2010. PMID: 24281035 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical